Education
About Us
Working with TipRanks
Follow Us
Roger Jeffs Insider Profile
4 Followers
Roger Jeffs, President & Co-CEO, Director at United Therapeutics, holds 57.51K shares in Axsome Therapeutics (Ticker: AXSM), holds 2.63M shares in Liquidia Technologies (Ticker: LQDA), holds 0.00 shares in Dova Pharmaceuticals (Ticker: DOVA).
Roger Jeffs United Therapeutics (UTHR)President & Co-CEO, Director
United Therapeutics (UTHR)
President & Co-CEO, Director
Ranked #3,339 out of 103,431 Corporate Insiders
Profitable Transactions
9 out of 10 Profitable Transactions
Average Return
+42.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Roger Jeffs holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 25, 2022 - May 25, 2023
Return:+139.50%
The most profitable trade made by Roger Jeffs
Roger Jeffs's Trading History
United Therapeutics
Feb 17, 2016
President & Co-CEO, Director
Uninformative Buy
592.20K
$10.97M
Axsome Therapeutics
Sep 02, 2025
Director
Uninformative Sell
1.67M
$7.07M
Sangamo Biosciences
Sep 07, 2018
Director
Informative Buy
100.45K
$5.26K
Sio Gene Therapies
―
―
―
―
Albireo Pharma
―
―
―
―
Dova Pharmaceuticals
Nov 12, 2019
―
Uninformative Sell
―
$0.00
Liquidia Technologies
Jul 15, 2025
CEO, Director
Uninformative Sell
91.66K
$70.92M
List of latest transactions for each holding click on a transaction to see Roger Jeffs's performance on stock
You May Also Like
Roger Jeffs insider profile FAQ
What is the percentage of profitable transactions made by Roger Jeffs?
The percentage of profitable transactions made by Roger Jeffs is 90%.
What is the average return per transaction made by Roger Jeffs?
The average return per transaction made by Roger Jeffs is 42.20%.
What stocks does Roger Jeffs hold?
Roger Jeffs holds: UTHR, AXSM, SGMO, SIOX, ALBO, DOVA, LQDA stocks.
What was Roger Jeffs’s latest transaction?
Roger Jeffs latest transaction was an Uninformative Sell of $1.67M.
What was Roger Jeffs's most profitable transaction?
Roger Jeffs’s most profitable transaction was an Informative Buy of LQDA stock on May 25, 2022. The return on the trade was 139.50%.
What is Roger Jeffs's role in United Therapeutics?
Roger Jeffs's role in United Therapeutics is President & Co-CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.